13F HOLDINGS REPORT
Vivo Capital, LLC
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001213900-23-039212
Total Value
$1.44B
Positions
48
Other Managers
0
Confidential Omitted
No
Holdings (48)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Sinovac Biotech Ltd. | SVA | 5,900,000 | $615.4M | 42.70% |
| 2 | Genetron Holdings Ltd | 37186H100 | 8,124,174 | $104.6M | 7.26% |
| 3 | Verona Pharma PLC | 925050106 | 4,249,918 | $85.3M | 5.92% |
| 4 | Harmony Biosciences Holdings Inc | HRMY | 2,606,247 | $85.1M | 5.90% |
| 5 | Terns Pharmaceuticals Inc | TERN | 6,657,992 | $78.8M | 5.47% |
| 6 | Viridian Therapeutics Inc | VRDN | 1,678,207 | $42.7M | 2.96% |
| 7 | Geron Corp | GERN | 19,282,834 | $41.8M | 2.90% |
| 8 | Avadel Pharmaceuticals PLC | 05337M104 | 3,761,438 | $34.5M | 2.39% |
| 9 | Tarsus Pharmaceuticals Inc | TARS | 2,262,200 | $28.4M | 1.97% |
| 10 | Astria Therapeutics Inc | 04635X102 | 1,681,199 | $22.4M | 1.55% |
| 11 | Vaxcyte Inc | PCVX | 579,508 | $21.7M | 1.51% |
| 12 | Cogent Biosciences Inc | COGT | 1,994,941 | $21.5M | 1.49% |
| 13 | Chinook Therapeutics Inc | 16961L106 | 872,151 | $20.2M | 1.40% |
| 14 | Ventyx Biosciences Inc | 92332V107 | 602,075 | $20.2M | 1.40% |
| 15 | VectivBio Holding AG | H9060V101 | 2,333,300 | $19.9M | 1.38% |
| 16 | ALX Oncology Holdings Inc | ALXO | 4,220,048 | $19.1M | 1.32% |
| 17 | Allakos Inc | 01671P100 | 4,120,134 | $18.3M | 1.27% |
| 18 | Zai Lab Ltd ADR | ZLAB | 416,640 | $13.9M | 0.96% |
| 19 | Legend Biotech Corp Sponsored | LEGN | 244,375 | $11.8M | 0.82% |
| 20 | Compass Therapeutics Inc | CMPX | 3,556,023 | $11.6M | 0.81% |
| 21 | Amyris, Inc | 03236M200 | 7,750,828 | $10.5M | 0.73% |
| 22 | Arcellx Inc. | ACLX | 290,713 | $9.0M | 0.62% |
| 23 | Instil Bio Inc | TIL | 12,486,787 | $8.3M | 0.57% |
| 24 | Bellus Health Inc | 07987C204 | 1,017,152 | $7.3M | 0.51% |
| 25 | Aclaris Therapeutics, Inc. | ACRS | 898,631 | $7.3M | 0.50% |
| 26 | Sera Prognostics Inc | SERA | 1,856,011 | $7.1M | 0.49% |
| 27 | KalVista Pharmaceuticals Inc. | KALV | 856,008 | $6.7M | 0.47% |
| 28 | Dyne Therapeutics Inc | DYN | 577,642 | $6.7M | 0.46% |
| 29 | Merus NV | N5749R100 | 353,600 | $6.5M | 0.45% |
| 30 | Aadi Bioscience Inc | WHWK | 509,572 | $6.5M | 0.45% |
| 31 | Olema Pharmaceuticals Inc | OLMA | 1,689,515 | $5.9M | 0.41% |
| 32 | IO Biotech Inc | IOBT | 3,015,545 | $5.7M | 0.39% |
| 33 | Bolt Therapeutics Inc | BOLT | 3,871,291 | $5.4M | 0.37% |
| 34 | DBV Technologies SA | DBVTF | 2,708,875 | $4.6M | 0.32% |
| 35 | Impel NeuroPharma Inc | 45258K109 | 2,884,789 | $4.0M | 0.28% |
| 36 | Iovance Biotherapeutics Inc | IOVA | 655,057 | $4.0M | 0.28% |
| 37 | Arrowhead Pharmaceuticals Inc | ARWR | 137,411 | $3.5M | 0.24% |
| 38 | Aligos Therapeutics Inc | ALGS | 3,547,030 | $3.1M | 0.22% |
| 39 | Gracell Biotechnologies Inc | 38406L103 | 1,463,983 | $2.7M | 0.19% |
| 40 | BioAtla Inc | BCAB | 637,181 | $1.7M | 0.12% |
| 41 | Aslan Pharmaceuticals Ltd | 04522R101 | 2,840,909 | $1.6M | 0.11% |
| 42 | Codexis, Inc | CDXS | 388,144 | $1.6M | 0.11% |
| 43 | Fulcrum Therapeutics Inc | FULC | 550,000 | $1.6M | 0.11% |
| 44 | Immunic Inc | IMUX | 632,184 | $941,954 | 0.07% |
| 45 | Rezolute Inc | RZLT | 489,473 | $939,788 | 0.07% |
| 46 | Minerva Surgical Inc | 60343F106 | 2,215,667 | $486,339 | 0.03% |
| 47 | Homology Medicines, Inc. | 438083107 | 370,068 | $381,170 | 0.03% |
| 48 | Precision Biosciences Inc | DTIL | 140,255 | $105,696 | 0.01% |